Search research articles
Contact Us
Filters
Showing results (201-210 of 224) with videos related to
Page
of 23
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2006
A sulfated metabolite produced by stf3 negatively regulates the virulence of Mycobacterium tuberculosis
Joseph D Mougous, Ryan H Senaratne, Christopher J Petzold, et al.
Gynecologic Oncology
|
March 17, 2020
Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy
F Mignot, S Gouy, A Schernberg, et al.
Nature Communications
|
January 10, 2013
The bipolar assembly domain of the mitotic motor kinesin-5
Seyda Acar, David B Carlson, Madhu S Budamagunta, et al.
Gynecologic Oncology
|
June 2, 2020
Implementation of image-guided brachytherapy as part of non-surgical treatment in inoperable endometrial cancer patients
S Espenel, M Kissel, M A Garcia, et al.
Gynecologic Oncology
|
October 30, 2021
Increasing global accessibility to high-level treatments for cervical cancers
C Chargari, M Arbyn, A Leary, et al.
Nature Structural & Molecular Biology
|
July 20, 2004
Identification, function and structure of the mycobacterial sulfotransferase that initiates sulfolipid-1 biosynthesis
Joseph D Mougous, Christopher J Petzold, Ryan H Senaratne, et al.
ESMO Open
|
March 7, 2022
Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials
E F Nassif, J-Y Blay, C Massard, et al.
Leukemia Research
|
January 30, 2017
Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease
M Annereau, C Willekens, L El Halabi, et al.
Gynecologic Oncology
|
May 18, 2017
Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative
R J Edmondson, E J Crosbie, M Nickkho-Amiry, et al.
ESMO Open
|
September 4, 2024
Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancer
A Xu-Vuillard, C Guerin-Charbonnel, F Bocquet, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 224) with videos related to
Sort By:
Page
of 23
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2006
A sulfated metabolite produced by stf3 negatively regulates the virulence of Mycobacterium tuberculosis
Joseph D Mougous, Ryan H Senaratne, Christopher J Petzold, et al.
Gynecologic Oncology
|
March 17, 2020
Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy
F Mignot, S Gouy, A Schernberg, et al.
Nature Communications
|
January 10, 2013
The bipolar assembly domain of the mitotic motor kinesin-5
Seyda Acar, David B Carlson, Madhu S Budamagunta, et al.
Gynecologic Oncology
|
June 2, 2020
Implementation of image-guided brachytherapy as part of non-surgical treatment in inoperable endometrial cancer patients
S Espenel, M Kissel, M A Garcia, et al.
Gynecologic Oncology
|
October 30, 2021
Increasing global accessibility to high-level treatments for cervical cancers
C Chargari, M Arbyn, A Leary, et al.
Nature Structural & Molecular Biology
|
July 20, 2004
Identification, function and structure of the mycobacterial sulfotransferase that initiates sulfolipid-1 biosynthesis
Joseph D Mougous, Christopher J Petzold, Ryan H Senaratne, et al.
ESMO Open
|
March 7, 2022
Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials
E F Nassif, J-Y Blay, C Massard, et al.
Leukemia Research
|
January 30, 2017
Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease
M Annereau, C Willekens, L El Halabi, et al.
Gynecologic Oncology
|
May 18, 2017
Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative
R J Edmondson, E J Crosbie, M Nickkho-Amiry, et al.
ESMO Open
|
September 4, 2024
Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancer
A Xu-Vuillard, C Guerin-Charbonnel, F Bocquet, et al.
Page
of 23